Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer

Journal of Chemotherapy

Volumn 5, Issue 5, 1993, Pages 344-347

  Farris, A ^a   Bisail, M ^a   Sarobba, M G ^a   Sanna, G ^a   Scotto, T ^a   Valzelli, S ^a   Intini, C ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SMALL CELL CARCINOMA; VOMITING;

EID: 0027139839     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1120009X.1993.11741080     Document Type: Article

References (0)